Europlasma S.A. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was EUR 7.17 million compared to EUR 7.24 million a year ago. Net loss was EUR 2.52 million compared to EUR 2.44 million a year ago.

Basic loss per share from continuing operations was EUR 0.295.